Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly accounts receivable is not available.GLUE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
GLUE Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Monte Rosa Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $9.00 M |
FAQ
- What is the all time high quarterly accounts receivable for Monte Rosa Therapeutics?
What is the all time high quarterly accounts receivable for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly accounts receivable is $9.00 M